netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Ustekinumab found 13 matches
Open monograph to display formulary status BNF Category
  Ustekinumab  (Stelara® ) Gastro-intestinal system - Cytokine inhibitors - 01.05.03
  Ustekinumab  (Stelara®) Skin - Drugs affecting the immune response - 13.05.03
  Ustekinumab  (Stelara®) Musculoskeletal and joint diseases - Cytokine modulators - 10.01.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (Jan 2015): Ustekinumab (Stelara): risk of exfoliative dermatitis (01.05.03)
link in drug section MHRA Drug Safety Update (Jan 2015): Ustekinumab (Stelara): risk of exfoliative dermatitis (13.05.03)
link in drug section MHRA Drug Safety Update (Jan 2015): Ustekinumab (Stelara): risk of exfoliative dermatitis (10.01.03)
link in drug section NICE TA180: Psoriasis - ustekinumab (Updated March 2017) (13.05.03)
link in drug section NICE TA340: Ustekinumab for treating active psoriatic arthritis (Updated March 2017) (10.01.03)
link in drug section NICE TA455 Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA455 Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA455 Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA456 Ustekinumab for moderately to severely active Crohn’s disease after previous treatment (01.05.03)
link in drug section NICE TA633: Ustekinumab for treating moderately to severely active ulcerative colitis (01.05.03)


 
netFormulary